SelfPap™ impacts the Cervical Cancer and STD Crisis
Cervical cancer kills an estimated 275,000 women every year. This entirely preventable disease is the second largest cancer killer of women in low and middle‐income countries, with most women dying in the prime of life.
For the facts we used current data derived from oﬃcial reports by the WHO (World Health Organization), United Nations, The World Bank, and IARC Globocan that highlight the inequity that women face depending on where they live. Fifty countries were selected to provide a snapshot of the world and reflect geographic, economic and population variations. The Cervical Cancer Crisis Card reveals that India ranks No. 1 in cervical cancer deaths with nearly 73,000 women dying of cervical cancer each year. China comes in second, followed by Brazil.
* STAT: 50% of women diagnosed with cervical cancer have NEVER had a pap test
* STAT: 10% of women diagnosed with cervical cancer have not had a pap test in 5 YEARS
Many more women die of cervical cancer in the developing world than in wealthier countries. In the industrialized world, eﬀective screening programs help to identify precancerous cervical lesions at a stage when they can easily be treated. But lack of screening programs in poorer countries means that the disease is not identified until it is too late, resulting in vastly greater mortality. Source: WHO/Globocan.
Globally the data is staggering and often under reported. Based upon a meta-analysis published by the World Health Organization (October 14, 2014), the adjusted HPV prevalence worldwide among women with normal cytological findings was estimated to be 11.7%.
The highest adjusted prevalence globally was found in:
- Sub-Saharan African regions
- Latin America and the Caribbean
- Eastern Europe
- South-Eastern Asia
However, country specific adjusted HPV prevalence in cervical specimens ranged from 1.6% to 41.9% worldwide.
About 79 million Americans are currently infected with HPV and about 14 million people become newly infected each year. It is now known that most cases of cervical cancer start with HPV. Even with HPV Vaccines, women still need routine Pap smear tests. The expectations that vaccines which primarily protect against the most common strains of HPV infections (HPV types 16 and 18), which cause about 70% of cervical cancers, may prevent cervical cancer worldwide are at present high. However, affordable pricing is the most critical factor to facilitate the introduction of HPV vaccines in low-and medium-resource countries in the short term. It is also extremely important that women continue to receive screening services because the current vaccines are being given to adolescent girls only, and even vaccinated girls should begin screening when they reach the recommended screening age since the vaccines do not provide protection for the 30% of chronic infections by HPV types other than HPV 16, 18, 6 and 11 that cause cervical cancer…
HPV-Associated Cervical Cancer Rates by Race and Ethnicity
It is estimated that about 11,967 new cases of HPV-associated cervical cancer are diagnosed in the United States each year.* More black and Hispanic women get cervical cancer than women of other races or ethnicities, possibly because of decreased access to Pap testing or follow-up treatment.
*Note: This study used cancer registry data to estimate the amount of potentially HPV-associated cancer in the United States by examining cancer in parts of the body and cancer cell types that are more likely to be caused by HPV. Cancer registries do not collect data on the presence or absence of HPV in cancer tissue at the time of diagnosis. In general, HPV is thought to be responsible for about 91% of cervical cancers.
HPV-Associated Cervical Cancer Rates by Race and Ethnicity, United States, 2004–2008
The graph above shows age-adjusted incidence rates for cervical cancer in the United States during 2004¬2008. “AI/AN” means American Indian/Alaska Native, and “A/PI” means Asian/Pacific Islander. The rates shown are the number of women who were diagnosed with cervical cancer for every 100,000 women. About 10 black women, 7 white women, 7 American Indian/Alaska Native women, and 7 Asian/Pacific Islander women were diagnosed with cervical cancer per 100,000 women. About 11 Hispanic women were diagnosed with cervical cancer per 100,000 women, compared to 7 non-Hispanic women.
This graph was adapted from Centers for Disease Control and Prevention (CDC). Human papillomavirus–associated cancers—United States, 2004–2008.MMWR 2012;61(15):258–261.